
Venture capital · Early stage
BVP
Dutch venture fund manager (Brightlands Venture Partners) backing science-based companies in healthcare, agri-food and sustainable chemicals, with four funds raised since 2004 and offices in Geleen and Venlo.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is BVP right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
BetaRounds BVP joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, BVP’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company BVP backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet BVP
Events where BVP’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
BVP is based in the Netherlands. It also has offices in Geleen and Venlo.
1 fund vehicle is on public registers (ESMA register), including Brightlands Venture Partners Fund IV B.V.
Stages: Seed, Series A. Sectors: Health tech, Medtech, Life sciences, Food and agtech, Climate and energy. From the firm’s own website.
Looks for founders with deep domain knowledge building around proprietary, defensible technology that tackles root causes in essential systems, often in regulated settings, and who aim for an eventual exit. Usually leads or co-leads seed to Series A rounds, acts as an active long-term partner from early validation to scaling, and weighs impact alongside financial returns under an SFDR Article 9 classification. From the firm’s own website.
€250K to €2M per investment, according to the firm’s own website.
BVP lists 27 portfolio companies on its website, including ACS Biomarker, Basic Pharma, Chemtrix, Circularise and Corporis Medical.
Firms whose websites list some of the same companies include Avant Bio, Inkef and Noso Capital.
Know before BVP’s next round is announced.
PRO tracks BVP’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.